DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation

BIT:CPR • NL0015435975

Current stock price

6.027 EUR
+0.04 (+0.75%)
Last:

This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPR.MI Profitability Analysis

1.1 Basic Checks

  • In the past year CPR was profitable.
  • In the past year CPR had a positive cash flow from operations.
  • CPR had positive earnings in each of the past 5 years.
  • CPR had a positive operating cash flow in each of the past 5 years.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • CPR has a better Return On Assets (4.27%) than 70.00% of its industry peers.
  • The Return On Equity of CPR (8.97%) is comparable to the rest of the industry.
  • With a decent Return On Invested Capital value of 6.57%, CPR is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • CPR had an Average Return On Invested Capital over the past 3 years of 6.98%. This is in line with the industry average of 7.47%.
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROIC 6.57%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CPR's Profit Margin of 11.35% is fine compared to the rest of the industry. CPR outperforms 70.00% of its industry peers.
  • In the last couple of years the Profit Margin of CPR has remained more or less at the same level.
  • CPR's Operating Margin of 19.74% is fine compared to the rest of the industry. CPR outperforms 70.00% of its industry peers.
  • In the last couple of years the Operating Margin of CPR has grown nicely.
  • CPR has a better Gross Margin (60.31%) than 86.67% of its industry peers.
  • CPR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CPR.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
  • Compared to 1 year ago, CPR has less shares outstanding
  • Compared to 5 years ago, CPR has more shares outstanding
  • The debt/assets ratio for CPR has been reduced compared to a year ago.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.61 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CPR has a better Altman-Z score (2.61) than 73.33% of its industry peers.
  • CPR has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as CPR would need 6.60 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.60, CPR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.59 indicates that CPR is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.59, CPR is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Altman-Z 2.61
ROIC/WACC0.99
WACC6.63%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • CPR has a Current Ratio of 2.22. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
  • CPR has a better Current ratio (2.22) than 83.33% of its industry peers.
  • A Quick Ratio of 0.96 indicates that CPR may have some problems paying its short term obligations.
  • CPR's Quick ratio of 0.96 is amongst the best of the industry. CPR outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.96
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CPR.MI Growth Analysis

3.1 Past

  • CPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.22%, which is quite impressive.
  • Measured over the past years, CPR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.04% on average per year.
  • The Revenue has decreased by -0.60% in the past year.
  • Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 11.48% on average per year.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.72% on average over the next years. This is quite good.
  • CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.29% yearly.
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0 0 0 0
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

3

4. CPR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • CPR is valuated rather expensively with a Price/Earnings ratio of 20.78.
  • CPR's Price/Earnings is on the same level as the industry average.
  • CPR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.73.
  • A Price/Forward Earnings ratio of 18.60 indicates a rather expensive valuation of CPR.
  • CPR's Price/Forward Earnings is on the same level as the industry average.
  • CPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.78
Fwd PE 18.6
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CPR.
  • CPR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.11
EV/EBITDA 12.25
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
  • CPR has a very decent profitability rating, which may justify a higher PE ratio.
  • CPR's earnings are expected to grow with 13.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.89
PEG (5Y)1.73
EPS Next 2Y9.68%
EPS Next 3Y13.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CPR.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.62%, CPR has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.74, CPR is paying slightly less dividend.
  • CPR's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

  • The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 22.52% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP22.52%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CPR.MI Fundamentals: All Metrics, Ratios and Statistics

DAVIDE CAMPARI-MILANO NV

BIT:CPR (3/20/2026, 9:30:44 AM)

6.027

+0.04 (+0.75%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners21.32%
Inst Owner ChangeN/A
Ins Owners50.85%
Ins Owner ChangeN/A
Market Cap7.42B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts71.85
Price Target7.1 (17.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)1.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-1.42%
Valuation
Industry RankSector Rank
PE 20.78
Fwd PE 18.6
P/S 2.43
P/FCF 19.11
P/OCF 10.79
P/B 1.92
P/tB 18.71
EV/EBITDA 12.25
EPS(TTM)0.29
EY4.81%
EPS(NY)0.32
Fwd EY5.38%
FCF(TTM)0.32
FCFY5.23%
OCF(TTM)0.56
OCFY9.27%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)2.89
PEG (5Y)1.73
Graham Number4.52
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROCE 8.89%
ROIC 6.57%
ROICexc 7.34%
ROICexgc 17.16%
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
FCFM 12.73%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Debt/EBITDA 3.02
Cap/Depr 201.82%
Cap/Sales 9.81%
Interest Coverage 6.43
Cash Conversion 91.62%
Profit Quality 112.13%
Current Ratio 2.22
Quick Ratio 0.96
Altman-Z 2.61
F-Score8
WACC6.63%
ROIC/WACC0.99
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year26.48%
EBIT Next 3Y15.06%
EBIT Next 5Y19.57%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%

DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 3 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


What is the profitability of CPR stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.


Can you provide the financial health for CPR stock?

The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 6 / 10.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 7.18% in the next year.